Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia

European Journal of Pharmacology

Volumn 377, Issue 2-3, 1999, Pages 175-182

  Aguirre Bañuelos, Patricia ^a   Castañeda Hernández, Gilberto ^a   López Muñoz, Francisco J ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Adenosine A1 receptor; Caffeine; cGMP; Ketorolac; Potentiation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CYCLIC GMP; CYCLIC NUCLEOTIDE; CYCLOHEXYLADENOSINE; KETOROLAC;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; FEMALE; INTRAARTICULAR DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADMINISTRATION, TOPICAL; ANALGESICS, NON-NARCOTIC; ANIMALS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIC GMP; CYCLOHEXYLAMINES; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FEMALE; KETOROLAC; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; TIME FACTORS;

EID: 0345104423     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00404-5     Document Type: Article

References (41)

1. Beubler E., Lambech P. Methylxanthines and intestinal absorption. Naunyn-Schmiedebergs Arch. Pharmacol. 229:1976;73-77.
2. Cass I.J., Frederik W.S. The augmentation of analgesic effect of aspirin with phenacetin and caffeine. Curr. Ther. Res. 4:1962;583-588.
3. Castañeda-Hernández G., Castillo-Méndez M.S., López-Muñoz F.J., Granados-Soto V., Flores-Murrieta F.J. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can. J. Physiol. Pharmacol. 72:1994;1127-1131.
4. Choi O.H., Shamim M.T., Padgett W.L., Daly J.W. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43:1988;387-397.
5. Collins C., Laird R.I., Richards P.T., Starmer G.A., Weyrauch S. Aspirin-caffeine interaction in the rat. J. Pharm. Pharmacol. 31:1979;611-614.
6. Debas H.T., Cohen M.M., Holubitsky I.B., Harrison R.C. Caffeine stimulated gastric acid and pepsin secretion dose-response studies. Scand. J. Gastroenterol. 6:1971;453-457.
7. 2+ dependent process. Prostaglandins. 18:1979;179-190.
8. Fialip J., Porteix A., Marty H., Eschalier A., Duchene-Marullaz P. Lack of importance of caffeine as an analgesic adjuvant of dipyrone in mice. Arch. Int. Pharmacodyn. 302:1989;86-95.
9. Flores-Acevedo D.M., Flores-Murrieta F.J., Castañeda-Hernández G., López-Muñoz F.J. Potentiation of the analgesic effect of tolmetin, a potent non-steroidal anti-inflammatory drug by caffeine in the rat. Pharm. Sci. 1:1995;441-444.
10. Flores-Murrieta F.J., Granados-Soto V., Hong E. Determination of ketorolac in blood and plasma samples by high performance liquid chromatography. Bolletino Chimico Farmaceutico. 133:1994;588-591.
11. Forbes J.A., Beaver W.T., Jones K.F., Kehm C.J., Smith W.K., Gongloff C.M., Zeleznock J.R., Smith J.W. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin. Pharmacol. Ther. 49:1991;674-684.
12. Fredholm B.B., Burnstock G., Kendal Harden T., Speedding M. Receptor nomenclature. Drug Dev. Res. 39:1996;461-466.
13. Gayawali K., Pandhi P., Sharma P.L. Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. Methods Find. Exp. Clin. Pharmacol. 13:1991;529-533.
14. Ghelardini C., Galeotti N., Bartolini A. Caffeine induced central cholinergic analgesia. Naunin-Schmiedeberg's Arch. Pharmacol. 356:1997;590-595.
15. Granados-Soto V., López-Muñoz F.J., Castañeda-Hernández G., Salazar L.A., Villarreal J.E., Flores-Murrieta F.J. Characterization of the analgesic effects of paracetamol and caffeine in the pain-induced functional impairment model in the rat. J. Pharm. Pharmacol. 45:1993;627-631.
16. Granados-Soto V., Flores-Murrieta F.J., Castañeda-Hernández G., López-Muñoz F.J. Evidence for the involvement of nitric oxide in the antinociceptive effect of ketorolac in the rat. Eur. J. Pharmacol. 277:1995;281-284.
17. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., Ferreira S.H. Evidence for the involvement of nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 287:1997;281-284.
18. Hatano Y., Mizumoto K., Yoshiyama T., Yamamoto M., Iranami H. Endothelium-dependent and -independent vasodilatation of isolated rat aorta induced by caffeine. Am. J. Physiol. 269:1995;H1679-H1684.
19. Karlsten R., Gordh T., Hartvig P., Post C. Effects of intrathecal injection of the adenosine receptor agonists R-phenylisopropyl-adenosine and N-ethylcarbaxamido-adenosine on nociception. Anesth. Analg. 71:1990;60-64.
20. Karlsten R., Gordh T., Post C. Local antinociceptive and hyperalgesic effects in the formalin test after peripheral administration of adenosine analogues in mice. Pharmacol. Toxicol. 70:1992;434-438.
21. Laska E.M., Sunshine A., Mueller F., Elvers W.B., Siegel C., Rubin A. Caffeine as an analgesic adjuvant. JAMA. 25:1984;1711-1718.
22. López-Muñoz F.J., Salazar L.A., Castañeda-Hernández G., Villarreal J.E. A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR). Drug Dev. Res. 28:1993;169-175.
23. López-Muñoz F.J., Castañeda-Hernández G., Flores-Murrieta F.J., Granados-Soto V. Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac. Eur. J. Pharmacol. 308:1996;275-277.
24. Malec D., Michalska E. The effect of methylxanthines on morphine analgesia in mice and rats. Pol. J. Pharmacol. Pharm. 40:1988;223-232.
25. Malmberg A.B., Yaksh T.L. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology. 79:1993;270-281.
26. Moertel C.G., Ahmann D.L., Taylor W.F., Schwartau N. Relief of pain by oral medications: a controlled evaluation of analgesic combinations. JAMA. 229:1974;55-59.
27. Nakamura I., Ohta Y., Kemmotsu O. Characterization of adenosine receptors mediating spinal sensory transmission related to nociceptive information in the rat. Anesthesiology. 87:1997;577-584.
28. Nozaki-Taguchi N., Yamamoto T. The interaction of FK409, a novel nitric oxide releaser, and peripherally administered morphine during experimental inflammation. Anesth. Analg. 86:1998;367-373.
29. Onrot J., Shaheen O., Biaggione I., Goldberg M.R., Feely J., Wilkinson G.R., Hollister A.S., Robertson D. Reduction of liver plasma flow by caffeine and theophylline. Clin. Pharmacol. Ther. 40:1986;506-510.
30. Person D.L., Kissin I., Brown P.T., Xavier A.V., Vinik H.R., Bradley E.L. Morphine-caffeine analgesic interaction in rats. Anesth. Analg. 64:1985;851-856.
31. Poon A., Sawynok J. Antinociception by adenosine analogs and inhibitors of adenosine metabolism in an inflammatory thermal hyperalgesia model in the rat. Pain. 74:1998;235-245.
32. Post C. Antinociceptive effects in mice after intrathecal injection of 5-N-ethylcarbaxamido adenosine. Neurosci. Lett. 51:1984;325-330.
33. Reeve A.J., Dickenson A.H. The roles of spinal adenosine receptors in the control of acute and more persistent nociceptive responses of dorsal horn neurons in the anesthetized rat. Br. J. Pharmacol. 116:1995;2221-2228.
34. Sawynok J., Yaksh T.L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45:1993;43-85.
35. Sawynok J., Reid A.R., Doak G.J. Caffeine analgesia in the rat hot plate and formalin tests. Pain. 61:1995;203-213.
36. Sawynok J., Reid A.R., Poon A. Peripheral antinociceptive effect of an adenosine kinase inhibitor, with augmentation by an adenosine inhibitor, in the rat formalin test. Pain. 74:1998;75-81.
37. Seegers A.J.M., Olling M., Jager L.P., Noordwijk J. The anti-inflammatory, analgesic and antipyretic activities of non-narcotic analgesic drug mixtures in rats. Arch. Int. Pharmacodyn. 251:1980;237-254.
38. Siegers C.P. Effects of caffeine on the absorption and analgesic effect of paracetamol in rats. Pharmacology. 10:1973;19-27.
39. Taiwo Y.O., Levine J.D. Direct cutaneous hyperalgesia induced by adenosine. Neuroscience. 38:1990;757-762.
40. Vinegar R., Truax J.F., Selph J.L., Welch R.M., White H.L. Potentiation of the anti-inflammatory and analgesic activity of aspirin by caffeine in the rat. Proc. Soc. Exp. Biol. Med. 151:1976;556-560.
41. Zimmermann M. Ethical guidelines for investigations on experimental pain in conscious animals. Pain. 16:1983;109-110.